Interviews to the Expert
Association of steroid use with survival in solid tumours
Interview with Fausto Petrelli, oncology unit, asst Bergamo ovest, Treviglio (Italy). Q.Steroids are commonly used in patients with solid tumours for supportive therapy. Your systematic review and metanalysis recently published in European Journal of Cancer seems to question the real…
Bridging the Age Gap in Breast Cancer: A treatment selection tool for the over-70s
Q. Surgery tends to be a bigger issue for older people, and physicians need reliable guidance on who is likely to benefit and who could be harmed. You looked at selection practices and outcomes at 56 breast units across the…
Liquid biopsy for early stage lung cancer moves closer
Interview with Christian Rolfo, MD, PhD, MBA, Dr.h.c. director of the Thoracic Medical Oncology and the Early Clinical Trials and Experimental Therapeutics Research Program investigator at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center. Q. Your article…
The cost of cancer in Europe
Interview with Thomas Hofmarcher, health economist, IHE - The Swedish Institute for Health Economics, Lund, Sweden. Q. Which is the origin of your idea of studying the cost of cancer in Europe? Does the Swedish Institute for Health Economics have a…
Cervical cancer: the SENTIX trial
Interview with David Cibula, MD, Department of Obstetrics and Gynaecology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. Q. Your recent paper in the European Journal of Cancer (EJC 137 (2020) 69-80) on the SENTIX…
Dose dense chemotherapy in Luminal B breast cancers
Interview with Lucia Del Mastro, MD, Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genova, Italy. Q. Your recent paper in the European Journal of Cancer (EJC 136 (2020) 43-51) on the GIM2 trial is clearly…